NecstGen


NecstGen is built upon a rich history of developments and innovations in regenerative medicine. Today Leiden’s ecosystem of academic and industrial partners continues to pioneer in research and the development of new regenerative therapies.

Employees

11-50

Links


Org chart

Melissa Van Pel
Head of Cell Therapy
Collapse
Gijsbert van Willigen
Biosafety Officer
Lynn de Boer
Technician
Marten Visser
Cell Therapy Specialist
Lindsay Mulder
Specialist Viral Vector
Diederik Lokhorst
Scientist Viral Vector
ton rabelink
Chief Scientific Officer & Founder
Óscar Bártulos
Lead Scientist-Cell Therapy


Offices

This company has no offices yet